IGF2BP3-TRNAU1AP Pathway Identified as Promising Therapeutic Target in Glioblastoma
核心洞察
Researchers identified TRNAU1AP (搜索) as a key protein driving glioblastoma (搜索) stem cell survival, with elevated levels correlating to worse patient outcomes.
TRNAU1AP (搜索) forms intracellular clusters that promote selenoprotein synthesis, protecting cancer stem cells from oxidative damage and therapy resistance.
The m6A reader protein IGF2BP3 (搜索) stabilizes TRNAU1AP (搜索) mRNA, and blocking the IGF2BP3-TRNAU1AP axis may render glioblastoma (搜索) cells more vulnerable to treatment.
A team of scientists from Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center (搜索), and the University of Texas MD Anderson Cancer Center has uncovered a novel protein pathway that could reshape the therapeutic landscape for glioblastoma (搜索) (GBM), the most aggressive form of brain cancer. Published in Neuro-Oncology, the study identifies TRNAU1AP (搜索) as a critical driver of glioblastoma stem cell survival and tumor progression, while also revealing an upstream regulatory mechanism involving the m6A reader protein IGF2BP3 (搜索) that may serve as a druggable vulnerability.
"We think we could potentially target to kill this tumor," said Suyun Huang, Ph.D., lead author of the study, member of the Cancer Biology research program at Massey and professor in the Department of Cellular, Molecular, and Genetic Medicine at the VCU School of Medicine. "If we have a way to inhibit these proteins, it could open up new pathways to treat this deadly disease."
The Clinical Challenge of Glioblastoma (搜索)
Glioblastoma (搜索) remains one of the most difficult malignancies to treat. The disease is driven by cancer stem cells that sustain tumor growth and confer resistance to standard therapies. Even with advances in treatment modalities including brachytherapy, surgery, and chemotherapy, the median survival rate stands at approximately 14 months — a modest improvement from the historical benchmark of less than one year. GBM tumors are known to rely on selenoproteins, a class of proteins critical to brain development and function, for their progression and survival.
TRNAU1AP (搜索): A Key Driver of Tumorigenesis
Through comprehensive analysis of GBM tumor samples and public multi-omic datasets, the research team demonstrated that TRNAU1AP (搜索) is essential for the proliferation, stemness, and tumorigenesis of glioblastoma (搜索) stem cells (GSCs). Critically, patients with higher levels of TRNAU1AP expression exhibited significantly worse survival outcomes.
Mechanistically, TRNAU1AP (搜索) functions by interacting with EEFSEC to form phase-separated intracellular complexes. These liquid-like clusters enhance EEFSEC binding to sec-tRNAsec, thereby promoting the efficient translation of several selective selenoproteins. These selenoproteins utilize selenium to protect cancer stem cells from oxidative damage and therapy-induced cellular stress, acting as key effectors mediating the oncogenic functions of TRNAU1AP.
IGF2BP3 (搜索): The Upstream Regulator
The study further established that the RNA-binding protein IGF2BP3 (搜索) — identified as the most dysregulated N6-methyladenosine (m6A) reader in GBM — serves as a critical upstream regulator of TRNAU1AP (搜索). IGF2BP3 binds directly to m6A-modified TRNAU1AP mRNA transcripts, enhancing their stability and preventing RNA degradation. This m6A-dependent transcript stabilization drives persistent TRNAU1AP protein overproduction, leading to increased selenoprotein synthesis and enhanced GSC stemness and tumorigenic potential.
The findings suggest that blocking the IGF2BP3 (搜索)-TRNAU1AP (搜索) signaling axis could dismantle glioblastoma (搜索) stem cell resilience and make these notoriously treatment-resistant cancer cells more vulnerable to therapeutic intervention.
Therapeutic Horizons
Looking ahead, Huang and colleagues are focused on developing small-molecule inhibitors of IGF2BP3 (搜索) capable of crossing the blood-brain barrier — a critical requirement for any effective GBM therapy. "A small-molecule inhibitor capable of entering the brain and disrupting IGF2BP3–RNA interactions could reduce the stability of these tumor-promoting transcripts and suppress glioblastoma (搜索) growth," Huang explained.
The research was supported by the Paul M. Corman, MD Chair in Cancer Research Endowment Fund, the National Center for Advancing Translational Sciences, and the CCTR Endowment Fund of Virginia Commonwealth University. The study employed a range of sophisticated methodologies including proteomics, spatial transcriptomics, RNA immunoprecipitation, polysome profiling, and phase-separation assays to characterize the TRNAU1AP (搜索)-EEFSEC interaction and elucidate IGF2BP3 (搜索)-dependent regulation.